The government-funded venture capital firm TMF Management Co (TMF管顧公司) yesterday said it is talking to several public and private investors to raise as much as NT$5 billion (US$172.89 million) by December, with the aim of putting Taiwan on the global biotech map.
The fund, called Taiwan Medtech Fund (TMF), got an injection of NT$1 billion from the Executive Yuan’s National Development Fund in June.
State-run firms including CPC Corp, Taiwan (台灣中油), China Steel Corp (中鋼), Taiwan Sugar Corp (台糖) and Taiwan Salt Co (台鹽) are involved in the talks and their combined investments will be not exceed NT$1 billion, TMF Management chairman Jang Yue-teh (張有德) said.
“We are also looking to private firms for capital,” he told reporters, adding that investor targets include entrepreneurs who have passion for medical health, especially those who have experience in the field or who had family members that have suffered from serious illnesses.
Hon Hai Group (鴻海集團) chairman Terry Gou’s (郭台銘) younger brother died of bone marrow cancer, while Quanta Computer Inc (廣達) chairman Barry Lam (林百里) has battled lung cancer.
When asked if firms such as Hon Hai were on the target list, Jang declined to comment, but said there would be more announcements soon.
“Taiwan has been talking about developing its biotech sector for more than 20 years,” he said. “But progress is going nowhere given a lack of talent, capital and an understanding of its importance.”
The venture capitalist plans to set up incubation centers that will generate, develop and -commercialize new ideas, and help market the end products in China, where the huge market could lead to big sales possibilities, said Stan Shih (施振榮), chairman of iD SoftCapital Inc (智融集團) and the founder of Acer Group (宏碁集團).
iD SoftCapital was invited by TMF Management to share its experiences and the former has not ruled out the possibility of investing in some projects.
The incubation centers would generate ideas mainly through research institutes and from academics, although they may come from anywhere in the world, as long as the ideas benefit Taiwan in certain ways, Jang said.
He said viable projects would either need to have their products produced here, or include -Taiwanese research and development teams, or Taiwan would have to have a say in the commercialization of the product, he said.
TMF is looking to invest in projects that research illnesses such as diabetes, sleeping disorders, cardiovascular disease and in fields including neurosciences and orthopedics, as well as remote and home-care medical services.
Jang is a partner in the US-based Vertical Group, a venture capital firm focused on medical technology and biotechnology.
He has more than 20 years of experience in various executive positions in the healthcare industry and currently serves on the boards of directors of Dynamic Implants, Forte Bio Inc and Inphenix Corp.
Prior to the Vertical Group, he was president and CEO of Embol-X, a private company engaged in the development of proprietary medical devices to prevent strokes during cardiac surgery.
IN THE AIR: While most companies said they were committed to North American operations, some added that production and costs would depend on the outcome of a US trade probe Leading local contract electronics makers Wistron Corp (緯創), Quanta Computer Inc (廣達), Inventec Corp (英業達) and Compal Electronics Inc (仁寶) are to maintain their North American expansion plans, despite Washington’s 20 percent tariff on Taiwanese goods. Wistron said it has long maintained a presence in the US, while distributing production across Taiwan, North America, Southeast Asia and Europe. The company is in talks with customers to align capacity with their site preferences, a company official told the Taipei Times by telephone on Friday. The company is still in talks with clients over who would bear the tariff costs, with the outcome pending further
NEGOTIATIONS: Semiconductors play an outsized role in Taiwan’s industrial and economic development and are a major driver of the Taiwan-US trade imbalance With US President Donald Trump threatening to impose tariffs on semiconductors, Taiwan is expected to face a significant challenge, as information and communications technology (ICT) products account for more than 70 percent of its exports to the US, Chung-Hua Institution for Economic Research (CIER, 中華經濟研究院) president Lien Hsien-ming (連賢明) said on Friday. Compared with other countries, semiconductors play a disproportionately large role in Taiwan’s industrial and economic development, Lien said. As the sixth-largest contributor to the US trade deficit, Taiwan recorded a US$73.9 billion trade surplus with the US last year — up from US$47.8 billion in 2023 — driven by strong
AI: Softbank’s stake increases in Nvidia and TSMC reflect Masayoshi Son’s effort to gain a foothold in key nodes of the AI value chain, from chip design to data infrastructure Softbank Group Corp is building up stakes in Nvidia Corp and Taiwan Semiconductor Manufacturing Co (TSMC, 台積電), the latest reflection of founder Masayoshi Son’s focus on the tools and hardware underpinning artificial intelligence (AI). The Japanese technology investor raised its stake in Nvidia to about US$3 billion by the end of March, up from US$1 billion in the prior quarter, regulatory filings showed. It bought about US$330 million worth of TSMC shares and US$170 million in Oracle Corp, they showed. Softbank’s signature Vision Fund has also monetized almost US$2 billion of public and private assets in the first half of this year,
POWELL SUCCESSOR: US Fed Governor Adriana Kugler’s resignation gives Donald Trump an opening on the board, potentially accelerating his decision on the next chair US President Donald Trump suddenly has a chance to fill an opening at the US Federal Reserve earlier than expected, after Fed Governor Adriana Kugler announced her resignation on Friday. It might also force him to pick the next Fed chair months sooner than he had anticipated. “The ball is now in Trump’s court,” LH Meyer/Monetary Policy Analytics Inc economist Derek Tang said. “Trump is the one who’s been putting pressure on the Fed to do this and that, and Trump says he wants to have his own people on. So now he has the opportunity.” Kugler’s exit unfolds amid unprecedented public pressure
RSS